{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:44:29Z","timestamp":1747165469499,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jns.2019.03.013","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T05:37:00Z","timestamp":1552714620000},"page":"119-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Neuronal intranuclear inclusion disease showing blepharoptosis and positive serum anti-acetylcholine receptor antibody without myasthenia gravis"],"prefix":"10.1016","volume":"400","author":[{"given":"Koji","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8865-4097","authenticated-orcid":false,"given":"Kenji","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroe","family":"Shirasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.03.013_bb0005","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1093\/brain\/aww249","article-title":"Clinicopathological features of adult-onset neuronal intranuclear inclusion disease","volume":"139","author":"Sone","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.03.013_bb0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5414\/NP300961","article-title":"Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease","volume":"35","author":"Yokoi","year":"2016","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.jns.2019.03.013_bb0015","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jnnp-2013-306084","article-title":"Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy","volume":"85","author":"Sone","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.03.013_bb0020","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1212\/WNL.0b013e3182166e13","article-title":"Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease","volume":"76","author":"Sone","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.03.013_bb0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","article-title":"A systematic review of diagnostic studies in myasthenia gravis","volume":"16","author":"Benatar","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2019.03.013_bb0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0022-510X(83)90095-3","article-title":"Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients","volume":"58","author":"Limburg","year":"1983","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.03.013_bb0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nmd.2011.06.751","article-title":"Acetylcholine receptor antibodies in patients with genetic myopathies: clinical and biological significance","volume":"22","author":"Lane","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2019.03.013_bb0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2169\/internalmedicine.36.312","article-title":"Amyotrophic lateral sclerosis with anti-acetylcholine receptor antibody","volume":"36","author":"Okuyama","year":"1997","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2019.03.013_bb0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00688467","article-title":"Intranuclear inclusions in muscle, nervous tissue, and adrenal gland","volume":"63","author":"Tateishi","year":"1984","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2019.03.013_bb0050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0046-8177(91)90296-2","article-title":"Cardiomyopathy and myocyte intranuclear inclusions in neuronal intranuclear inclusion disease: a case report","volume":"22","author":"Oyer","year":"1991","journal-title":"Hum. Pathol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19301364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19301364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T09:05:08Z","timestamp":1555491908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19301364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":10,"alternative-id":["S0022510X19301364"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.03.013","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal intranuclear inclusion disease showing blepharoptosis and positive serum anti-acetylcholine receptor antibody without myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}